Publicly available data revealed that Survival Probability was significantly worse in CRC cancer patients for whom BRD9 transcript expression was high in adenocarcinomas as compared with those harboring relatively low BRD9 levels (Figure 1A). Here, BRD9 is linked to adenocarcinoma.